Efficacy and Safety of M281 in Adults with Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study with a Long-term Open-label Extension Protocol# MOM-M281-006
Primary Objective
The primary objective of this study is to evaluate the efficacy of nipocalimab in patients with wAIHA.
Details
Age
Adult
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Ara Metjian, MD
Study ID
Protocol Number: 21-3149
More information available at ClinicalTrials.gov: NCT04119050
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers